- Home
- KPRX vs AIRI Comparison
KPRX vs AIRI Comparison
Compare KPRX & AIRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KPRX | AIRI |
|---|---|---|
| Founded | 1998 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.3M | 12.3M |
| IPO Year | 2014 | 2013 |
Fundamental Metrics
Financial Performance| Metric | KPRX | AIRI |
|---|---|---|
| Price | $2.67 | $2.66 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | 11.8K | ★ 22.2K |
| Earning Date | 05-08-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 24.39 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $47,921,000.00 |
| Revenue This Year | N/A | $6.43 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.76 | $2.30 |
| 52 Week High | $2.95 | $3.95 |
Technical Indicators
Market Signals| Indicator | KPRX | AIRI |
|---|---|---|
| Relative Strength Index (RSI) | 56.06 | 48.51 |
| Support Level | $2.45 | $2.55 |
| Resistance Level | $2.72 | $2.76 |
| Average True Range (ATR) | 0.08 | 0.08 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 84.78 | 22.22 |
Price Performance
Historical ComparisonAbout KPRX Kiora Pharmaceuticals Inc.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
About AIRI Air Industries Group
Air Industries Group is an aerospace and defense company. Its manufacturers of precision components and assemblies for large aerospace and defense prime contractors. The company products include landing gears, flight controls, engine mounts and components for aircraft jet engines, ground turbines and other complex machines. The ultimate end-user of products is the U.S. Government, international governments, and commercial global airlines.